Clinical Trials Browser

Terminated × Inflammatory Breast Neoplasms × Docetaxel × Clear all

NCT00118053 2013-11-20

Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer

Phase 2 Terminated

5 enrolled 6 charts

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00343512 2012-04-27

Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Phase 2 Terminated

34 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms